Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  RaySearch Laboratories AB (publ)    RAY B   SE0000135485

RAYSEARCH LABORATORIES AB (PUBL)

(RAY B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

RaySearch Laboratories publ : Pioneering oncology information system RayCare 4A arrives with new functionalities and enhancements

share with twitter share with LinkedIn share with facebook
06/29/2020 | 06:41am EDT

RaySearch Laboratories AB (publ) shares news of the release of oncology information system RayCare®* 4A. New functionalities include dynamic team management, scripting support, and an improved patient chart.

[image]

RayCare 4A has been carefully designed to further promote efficiency and safety by reducing routine manual tasks and handovers. Workflow management capabilities are enhanced by the introduction of task management for clinical teams supported by a dedicated workspace, the Team Home. The Team Home enables dynamic and versatile management of tasks for different users. It is now also possible to manage workflows and appointments for medical oncology and surgery in parallel with a radiotherapy workflow. 

The novel feature RayCare scripting adds additional automation capabilities and allows for further streamlining of workflows to ensure that clinical protocols are followed. The user-defined Python scripts can be run either automatically from tasks in the workflow without user interaction or manually via a console. The automation support provided by tasks is further developed by introducing support for forks in the workflow based on script responses from the RayCare script tasks or from the script tasks connected to the treatment planning system RayStation®*. This is designed to enable users to create advanced support for use cases such as plan comparison.

Other highlights of RayCare 4A include several new workspaces and enhancements in the patient chart. These include extended capabilities for documenting chart notes, clinical profile and history of the patient, a patient specific image management view, and a dedicated view for offline image reviews. PACS has been extended with archiving capabilities and the image viewer now supports making annotations.

Johan Löf, founder and CEO, RaySearch, says: "I am very proud of the progress we have made with RayCare. Each new release offers exciting new possibilities for oncology teams and I am looking forward to seeing this latest release in clinical use. Scripting has proven to be a tremendously powerful tool in RayStation, and I think the potential for scripting in RayCare is equally great."

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Peter Thysell, CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide. 

About RayCare
RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow's requirements for advanced analytics and decision support in mind.

* Subject to regulatory clearance in some markets.

 

More information about RaySearch is available at www.raysearchlabs.com
 

https://news.cision.com/raysearch-laboratories/r/pioneering-oncology-information-system-raycare-4a-arrives-with-new-functionalities-and-enhancements,c3144022

https://mb.cision.com/Main/1102/3144022/1271403.pdf

https://news.cision.com/raysearch-laboratories/i/raycare-4a-pr,c2801128

(c) 2020 Cision. All rights reserved., source Press Releases - English


share with twitter share with LinkedIn share with facebook
All news about RAYSEARCH LABORATORIES AB (PUBL)
10/23RAYSEARCH LABORATORIES : will present further advances in machine learning and s..
AQ
09/16RAYSEARCH LABORATORIES : Cutting-edge cancer treatment comes to Belgium with the..
AQ
08/28RAYSEARCH LABORATORIES : RayStation in clinical use at both of Spain's proton ce..
AQ
08/26RAYSEARCH LABORATORIES : Interim report January 1 - June 30, 2020
AQ
07/15RAYSEARCH LABORATORIES PUBL : and TAE Life Sciences announce agreement on RaySta..
AQ
07/09RAYSEARCH LABORATORIES PUBL : Further clinical implementation of deep learning s..
AQ
06/30RAYSEARCH LABORATORIES PUBL : Bulletin from the Annual General Meeting 2020
AQ
06/29RAYSEARCH LABORATORIES PUBL : Machine learning algorithm from RaySearch enhances..
AQ
06/29RAYSEARCH LABORATORIES PUBL : Pioneering oncology information system RayCare 4A ..
AQ
06/24RAYSEARCH LABORATORIES PUBL : Axim Nuclear & Oncology to supply RaySearch system..
AQ
More news
Financials
Sales 2020 779 M 89,1 M 89,1 M
Net income 2020 66,5 M 7,61 M 7,61 M
Net cash 2020 15,0 M 1,72 M 1,72 M
P/E ratio 2020 41,5x
Yield 2020 0,37%
Capitalization 2 746 M 313 M 314 M
EV / Sales 2020 3,51x
EV / Sales 2021 2,98x
Nbr of Employees 396
Free-Float 69,7%
Chart RAYSEARCH LABORATORIES AB (PUBL)
Duration : Period :
RaySearch Laboratories AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RAYSEARCH LABORATORIES AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 93,50 SEK
Last Close Price 80,10 SEK
Spread / Highest target 18,6%
Spread / Average Target 16,7%
Spread / Lowest Target 14,9%
EPS Revisions
Managers
NameTitle
Johan Löf President, Chief Executive Officer & Director
Lars Micael Wollung Chairman
Peter Thysell Chief Financial Officer
Kjell Eriksson Chief Research Officer
Carl Filip Bergendal Director
Sector and Competitors
1st jan.Capitalization (M$)
RAYSEARCH LABORATORIES AB (PUBL)-25.28%313
VEEVA SYSTEMS INC.111.04%44 773
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED126.11%35 297
OMNICELL, INC.3.37%3 612
SECTRA AB (PUBL)54.99%2 660
PRO MEDICUS LIMITED50.47%2 492